| Ironing out the cross talk between FGF23 and inflammation V David, C Francis, JL Babitt American Journal of Physiology-Renal Physiology 312 (1), F1-F8, 2017 | 102 | 2017 |
| Inflammation regulates fibroblast growth factor 23 production C Francis, V David Current opinion in nephrology and hypertension 25 (4), 325-332, 2016 | 101 | 2016 |
| DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease C Dussold, C Gerber, S White, X Wang, L Qi, C Francis, M Capella, ... Bone research 7 (1), 12, 2019 | 70 | 2019 |
| Precision therapeutic targets for COVID-19 ZA Krumm, GM Lloyd, CP Francis, LH Nasif, DA Mitchell, TE Golde, ... Virology journal 18, 1-22, 2021 | 57 | 2021 |
| Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease C Francis, G Courbon, C Gerber, S Neuburg, X Wang, C Dussold, ... Kidney international 96 (6), 1346-1358, 2019 | 54 | 2019 |
| Genetic background influences cardiac phenotype in murine chronic kidney disease S Neuburg, C Dussold, C Gerber, X Wang, C Francis, L Qi, V David, ... Nephrology Dialysis Transplantation 33 (7), 1129-1137, 2018 | 36 | 2018 |
| Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease G Courbon, C Francis, C Gerber, S Neuburg, X Wang, E Lynch, T Isakova, ... Bone research 9 (1), 35, 2021 | 33 | 2021 |
| Immune escape after adoptive T-cell therapy for malignant gliomas TJ Wildes, KA Dyson, C Francis, B Wummer, C Yang, O Yegorov, D Shin, ... Clinical Cancer Research 26 (21), 5689-5700, 2020 | 31 | 2020 |
| Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy M Martinez-Calle, G Courbon, B Hunt-Tobey, C Francis, J Spindler, ... The Journal of clinical investigation 133 (11), 2023 | 6 | 2023 |
| Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis BDV Dean, T Wildes, J Dean, O Yegorov, C Yang, D Shin, C Francis, ... Journal for Immunotherapy of Cancer 11 (2), 2023 | 2 | 2023 |
| Lipocalin-2 regulates FGF23 production in chronic kidney disease G Courbon, C Francis, C Gerber, S Neuburg, M Capella, X Wang, ... JOURNAL OF BONE AND MINERAL RESEARCH 34, 15-15, 2019 | 2 | 2019 |
| SINGLE CELL RNASEQ OF PBMCS FROM NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS BDV Dean, O Yegorov, J Figg, LF Font, D Jin, C Francis, A Reid, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| ADOPTIVE CELLULAR THERAPY OVERCOMES GLIOMA IMMUNE ESCAPE BY DISRUPTING MDSC PROLIFERATION AND RECRUITMENT J Figg, C Francis, D Jin, BDV Dean, LF Font, A Reid, B McDonald, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| INVESTIGATING REPROGRAMING OF THE GBM'S TUMOR MICROENVIRONMENT AS A RESULT OF CO-TRANSFER OF HEMATOPOIETIC STEM CELLS (HSCS) WITH ADOPTIVE CELLULAR THERAPY. A Reid, D Jin, BDV Dean, LF Font, C Francis, J Figg, C Flores NEURO-ONCOLOGY 25, 2023 | | 2023 |
| IMMU-36. PD-1KO HEMATOPOIETIC STEM CELLS RAPIDLY DIFFERENTIATE INTO GLIOMA-INFILTRATING EFFECTOR T-CELLS C Francis, BDV Dean, LF Font, J Figg, K Long-James, A Reid, D Jin, ... Neuro-Oncology 25 (Supplement_5), v150-v150, 2023 | | 2023 |
| EXTH-07. NEOADJUVANT PD1 BLOCKADE ALTERS THE TUMOR MICROENVIRONMENT POST-SURGERY IN A PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA L Hoang-Minh, D Mitchell, K Klippel, C Yang, V Trivedi, B Doonan, ... Neuro-Oncology 25 (Supplement_5), v225-v225, 2023 | | 2023 |
| 429 Divergent mechanisms of dendritic cell dysfunction in primary and adoptive cellular therapy-escaped gliomas D Jin, B Dean, A Reid, J Figg, C Francis, L Font, D Hilferty, M Sebastian, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| GLIOMA-14 ELUCIDATING THE CELL-CELL INTERACTIONS AND GEO-SPATIAL ORIENTATION OF M2 POLARIZED MACROPHAGES/MICROGLIA WITHIN GBM'S TME AND INVESTIGATING THEIR IMMUNOSUPPRESSIVE … A Reid, D Jin, BDV Dean, L Falceto-Font, C Francis, C Flores Neuro-Oncology Advances 5 (Suppl 4), iv3, 2023 | | 2023 |
| Stem cell immunomodulatory therapy for covid-19 infection D Mitchell, C Flores, C Francis US Patent App. 17/916,502, 2023 | | 2023 |
| IMMU-21. ELUCIDATING THE CELLULAR MECHANISMS OF THERAPEUTIC BENEFIT UNDERLYING ADOPTIVE CELLULAR THERAPY IN MODELS OF GLIOMA J Figg, C Francis, D Jin, BDV Dean, A Reid, D Hilferty, B McDonald, ... Neuro-Oncology 25 (Suppl 1), i54, 2023 | | 2023 |
